by alfie | May 3, 2024 | news and press
< Back to Sanius content Sanius Health, a London-based RWE Generation Firm and AI-Powered Patient Ecosystem, Pivotal in NICE Approval of Novel Sickle Cell Disease Therapy Voxelotor for NHS use Earlier today, UK-based regulator the National Institute for Health and...
by purvi | Apr 3, 2024 | news and press
< Back to Sanius content Four Questions with Sanne Lugthart In the buildup to the Haematology Patient and Carers’ Congress 2024, we sat down with Dr Sanne Lugthart, consultant haematologist at University Hospitals Bristol NHS Foundation Trust. How did you first get...
by alfie | Jan 15, 2024 | news and press
< Back to Sanius content Therapeutic Innovation Through Pre-, Peri- and Post-Trial Digitalisation. I have often highlighted this to clinical, industry, and CRO colleagues – maybe to anyone who would listen. Clinical trials are important. They are harder and more...
by alfie | Jan 5, 2024 | news and press
< Back to Sanius content AI platform Sanius Health and primary care provider Modality Partnership announce £225m deal Sanius Health has announced a deal valued at £225 million which will see its data, research and personalised health patient AI platform leveraged...
by alfie | Dec 11, 2023 | news and press
< Back to Sanius content 7000 Research Insights into Innovations and Cutting-edge Science in Haematology: Improving Outcomes, Access and New Medicines We’re heading into the home stretch of 2023, which will be marked by one last congress for the year. This...
by alfie | Dec 11, 2023 | news and press
< Back to Sanius content Advancements in Real-World Healthcare-Focused AI | A Patient Use Case in Vaso-Occlusive Crisis Prediction As we accelerate through our AI journey in improving healthcare for patients with sickle cell disease (SCD), a core focus has been...